Quantitative Investment Management LLC increased its position in Humana Inc (NYSE:HUM) by 42.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 27,200 shares of the insurance provider’s stock after purchasing an additional 8,100 shares during the quarter. Quantitative Investment Management LLC’s holdings in Humana were worth $6,747,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Nationwide Fund Advisors lifted its stake in shares of Humana by 0.4% in the 3rd quarter. Nationwide Fund Advisors now owns 170,587 shares of the insurance provider’s stock valued at $41,560,000 after purchasing an additional 758 shares during the period. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Humana by 68.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 4,724 shares of the insurance provider’s stock valued at $1,151,000 after purchasing an additional 1,912 shares during the period. Gamco Investors INC. ET AL lifted its stake in shares of Humana by 71.5% in the 3rd quarter. Gamco Investors INC. ET AL now owns 8,875 shares of the insurance provider’s stock valued at $2,162,000 after purchasing an additional 3,700 shares during the period. Sei Investments Co. lifted its stake in shares of Humana by 97.7% in the 3rd quarter. Sei Investments Co. now owns 52,224 shares of the insurance provider’s stock valued at $12,723,000 after purchasing an additional 25,808 shares during the period. Finally, New York State Common Retirement Fund lifted its stake in shares of Humana by 1.1% in the 3rd quarter. New York State Common Retirement Fund now owns 379,800 shares of the insurance provider’s stock valued at $92,531,000 after purchasing an additional 4,000 shares during the period. Institutional investors own 97.85% of the company’s stock.
In other news, SVP Cynthia H. Zipperle sold 1,196 shares of the business’s stock in a transaction on Friday, March 9th. The stock was sold at an average price of $273.33, for a total value of $326,902.68. Following the completion of the transaction, the senior vice president now owns 7,771 shares in the company, valued at $2,124,047.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the transaction, the vice president now owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. Insiders sold 41,775 shares of company stock valued at $11,169,845 in the last 90 days. Company insiders own 0.60% of the company’s stock.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The firm had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. During the same quarter in the previous year, the business earned $2.34 earnings per share. The company’s revenue was up 2.4% on a year-over-year basis. research analysts expect that Humana Inc will post 13.81 EPS for the current fiscal year.
Humana declared that its board has authorized a stock buyback program on Thursday, December 14th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the insurance provider to buy shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 0.75%. This is a boost from Humana’s previous quarterly dividend of $0.40. Humana’s payout ratio is currently 9.59%.
A number of brokerages have issued reports on HUM. Cantor Fitzgerald reiterated a “hold” rating and set a $230.00 price objective on shares of Humana in a research note on Tuesday, December 5th. Cowen reiterated a “buy” rating and set a $285.00 price objective on shares of Humana in a research note on Wednesday, December 13th. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Goldman Sachs Group began coverage on Humana in a research note on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective for the company. Finally, Jefferies Group upgraded Humana from a “hold” rating to a “buy” rating and set a $221.00 price objective for the company in a research note on Friday, January 12th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $270.47.
TRADEMARK VIOLATION WARNING: This story was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.tickerreport.com/banking-finance/3259543/humana-inc-hum-stake-raised-by-quantitative-investment-management-llc.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.